Top

Katherine A. Hutcheson, Ph.D.

Department of Head and Neck Surgery, Division of Surgery

About Dr. Katherine A. Hutcheson

Dr. Katherine A. Hutcheson is a tenured Professor in the Department of Head and Neck Surgery with dual appointment in the Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center. She serves as Chief for Speech Pathology and Audiology, Fellowship Director for Audiology and Oncologic Speech Pathology, and Deputy Director of Head and Neck Surgery Clinical Research and is adjunct faculty at the University of Houston. Dr. Hutcheson is a clinician-scientist, practicing as a Speech Language Pathologist for 20 years with Board Certification as a Specialist in Swallowing and Swallowing Disorders (BCS-S), and a Fellow of the American Speech-Language-Hearing Association. She serves as Associate Editor for the journals of Dysphagia and Head and Neck. Dr. Hutcheson leads a globally recognized program of practice oriented clinical research and has authored over 175 peer-reviewed and invited articles with funding support from the National Institutes of Health, Patient Centered Outcomes Research Institute, the Department of Defense, the MD Anderson Institutional Research Grant Award program, philanthropic and foundation fun ding after her post-doctoral funding by the Cancer Prevention Research Institute of Texas UT Health Innovation Training Program.

Primary Appointment

Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Section Chief, Speech Pathology and Audiology, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Lecturer, Department of Communication Sciences and Disorders, The University of Houston College of Liberal Arts and Social Sciences, Houston, TX

Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Interests

Speech and swallowing function after head and neck cancer treatment.

Measurement of functional outcomes in head and neck cancer patients.

Complications and outcomes of surgical prosthetic voice restoration after laryngectomy.

Radiation-associated dysphagia.

Education & Training

Degree-Granting Education

2010	The University of Texas School of Public Health, Houston, TX, USA, Ph.D, Epidemiology, Minor: Biostatistics, Behavioral Science
2004	Baylor University, Waco, TX, USA, M.S, Communication Sciences and Disorders
2002	Baylor University, Waco, TX, USA, B.A, Communication Sciences and Disorders

Board Certifications

2012	Board Certified Swallowing Specialist awarded by The Specialty Board on Swallowing and Swallowing Disorders, American Speech-Language-Hearing Association

Experience & Service

Academic Appointments

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2020

Associate Professor, Department of Head and Neck Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2020

Administrative Appointments/Responsibilities

Oncologic Speech-Language Pathology Fellowship Director, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present

AUD Fellowship Program Director, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, 2020 - Present

Director of Research for the Section of Speech Pathology and Audiology, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

Director, Voice Center, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - Present

Deputy Director of Head and Neck Surgery Clinical Research, Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

Associate Director of Research for the Section of Speech Pathology and Audiology, Department of Head and Neck Surgery - Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2020

Other Appointments/Responsibilities

Speech-Language Pathologist, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004 - 2010

Institutional Committee Activities

Member, Clinical Database Data Governance Committee, MD Anderson Stiefel Oropharynx Program, 2021 - Present

Honors & Awards

2012	Best Faculty Poster Award, Cancer Survivorship Research Retreat, The University of Texas MD Anderson Cancer Center
2012	Poster Competition Award, 2nd place, Triological Society 2012 Combined Sections Meeting, Miami Beach, FL
2011	Poster Competition Award, 2011 Oral Oncology: Oncologic Dentistry & Maxillofacial Prosthetics Symposium, The University of Texas MD Anderson Cancer Center
2008	Yul Brynner Foundation and ASHA Special Interest Division 13-Swallowing and Swallowing Disorders New Investigators Grant, Dysphagia Research Society 16th Annual Meeting
2008	Travel Award, American Speech-Language-Hearing Association Lessons for Success Research Conference: Developing the Emerging Scientist
2007	ASHA Research Mentoring Pair Travel Award, American Speech-Language-Hearing Association 17th Annual Research Symposium: Genetic and Biological Pathways Underpinning Communication Disorders Across the Lifespan
2007	Science and Research Team Convention Registration Award, American Speech-Language-Hearing Association
2005	ASHA Convention Registration Award for Research for Recent Graduates, American Speech-Language-Hearing Association Special Interest Division 2-Neurophysiology and Neurogenic Speech and Language Disorders
2001 - 2003	Casey Merit Scholar, Baylor University
2000 - 2003	Dean's Academic Honor List, Baylor University
1999 - 2003	Presidential Scholar, Baylor University

Professional Memberships

American Head and Neck Society, Los Angeles, CA

Associate Fellow, 2014 - Present

American Board of Swallowing and Swallowing Disorders

Specialty Board on Swallowing and Swallowing Disorders, Applications Committee, 2014 - 2017

American Cancer Society Head & Neck Cancer Clinical Survivorship Care Guidelines Development Workgroup

Member, 2012 - Present

Texas Speech-Language-Hearing Association

Future Health Care Funding Task Force, Expert in Laryngectomy/Head and Neck Cancer, 2012 - 2014

Dysphagia Research Society

Full Member, 2011 - Present

American Speech-Language-Hearing Association

State Medicare Administrative Contactor Network Representative, 2010 - Present

Texas Speech-Language-Hearing Association

Chair, Medical Speech Pathology Task Force, 2010 - 2012

American Speech-Language-Hearing Association

Member, Special Interest Division 13 - Swallowing and Swallowing Disorders, 2005 - Present

Houston Association for Communication Disorders

Vice President, Membership, 2005 - 2007

American Speech-Language-Hearing Association

Member, 2004 - Present

Texas Speech-Language-Hearing Association

Member, 2004 - Present

Houston Association for Communication Disorders

Member, 2004 - Present

Houston Association for Communication Disorders

Committee Chairperson, Membership, 2004 - 2005

Selected Publications

Peer-Reviewed Articles

Manduchi B, Fitch MI, Ringash JG, Howell D, Hutcheson KA, Martino R. The Acceptability of Behavioural Swallowing Interventions for Head and Neck Cancer Patients During Radiotherapy: A Qualitative Study Exploring Experiences of Clinical Trial Speech-Language Pathologists. Dysphagia 39(3):412-423, 2024. e-Pub 2023. PMID: 37914886.
Barbon CEA, Warneke CL, Ledger B, Rogus-Pulia N, Cunningham L, Coyle JL, Levesque-Boissonneault C, Alvarez C, Valencia D, Hutcheson KA. Reliability and confidence of dynamic imaging grade of swallowing toxicity (DIGEST) rating among research and clinical speech pathologists: A multi-site study. Dysphagia, 2024.
Hutcheson KA, Eldridge EF, Warneke CL, Buoy SN, Tang X, Macdonald C, Alcarez C, Barringer DA, Barbon CEA, Ebersole BM, McMillan H, Montealegre JR. Clinical Implementation of DIGEST as evidence-based practice tool for videofluoroscopy in oncology: A six-year single institution implementation evaluation. Dysphagia, 2024.
Ebersole BM, Zafereo M, Hutcheson KA. A custom device for managing recurrent tracheoesophageal voice prosthesis dislodgement and aspiration due to treatment refractory, severely enlarged puncture: a video case report. Head Neck 46(6):1526-1532, 2024. e-Pub 2024. PMID: 38576171.
Shinn E, Garden A, Chen M, Basen-Engquist K, Fellman B, Hutcheson K, Morrison W, Peterson S, Li L. Self-management intervention improves patient adherence to swallowing exercies during radiation for head and neck cancer. Head and Neck, 2024.
Anderson BJ, Moreno AC, Qing Y, Lee JJ, Johnson FM, Lango MN, Barbon CEA, Tripuraneni L, Sahli A, Piper V, Gross N, Fuller CD, Lai SY, Myers JN, Hutcheson KA. Revisiting feeding tube utilization in oropharynx cancer: 6-year prospective registry analysis. Otolaryngol Head Neck Surg 170(5):1319-1330, 2024. e-Pub 2024. PMID: 38353360.
Carlander, A, Hutcheson KA. Clinical and prognostic differences in oropharyngeal squamous cell carcinoma in USA and Denmark, two HPV high-prevalence areas. European Journal of Cancer, 2024. PMID: 38452723.
Moreno, AC, Hutcheson KA. International Expert-Based Consensus Definition, Staging Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Inter-Disciplinary Modified Delphi Study. Journal of Clinical Oncology, 2024. PMID: 38645105.
Hansen NJ, Woodman K, Buoy S, Mao S, Barbon CEA, Lai SY, Fuller CD, Hutcheson KA, Sanchez B. Tongue electrical impedance myography correlates with functional, neurophysiologic, and clinical outcome measures in long-term oropharyngeal cancer survivors with and without hypoglossal neuropathy: An exploratory study. Head Neck 46(3):581-591, 2024. e-Pub 2023. PMID: 38133080.
Rafeedi T, Abdal A, Polat B, Hutcheson KA, Shinn E, Lipomi D. Wearable, epidermal devices for assessment of swallowing function. Flexible Electronics. e-Pub 2023.
McDowell L, Hutcheson KA, Ringash J. Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer. Lancet Oncol 24(10):e396, 2023. e-Pub 2023. PMID: 37797634.
Dohopolski MJ, Diao K, Hutcheson KA, Akhave NS, Goepfert RP, He W, Lei XJ, Peterson SK, Shen Y, Sumer BD, Smith BD, Sher DJ. Long-term Patient-Reported Outcomes in a Population-Based Cohort Following Radiotherapy vs Surgery for Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 149(8):697-707, 2023. e-Pub 2023. PMID: 37382943.
Starmer HM, Hutcheson KA, Patterson J. Internal oedema and dysphagia characteristics in patients with head and neck cancer. Clin Otolaryngol 48(4):700-704, 2023. e-Pub 2023. PMID: 36918287.
Mayo-Yáñez M, Ramos-Neble MD, Cabo-Varela I, Chiesa-Estomba CM, Lechien JR, Fakhry N, Maniaci A, Hutcheson KA. Tissue augmentation treatment for periprosthetic leakage in patients who have undergone a total laryngectomy: A systematic review. Clin Otolaryngol 48(4):515-526, 2023. e-Pub 2023. PMID: 37012583.
Shinn EH, Garden AS, Peterson SK, Leupi DJ, Chen M, Blau R, Becerra L, Rafeedi T, Ramirez J, Rodriquez D, VanFossen F, Zehner S, Mercier P, Wang J, Hutcheson KA, Hanna E, Lipomi D. Iterative patient testing of a stimuli-responsive swallowing activity sensor to promote extended user engagement during the first year after radiation. JMIR Cancer, 2023.
Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes 7(1):48, 2023. e-Pub 2023. PMID: 37237077.
Kuhn MA, Gillespie MB, Ishman SL, Ishii LE, Brody R, Cohen E, Dhar SI, Hutcheson KA, Jefferson G, Johnson F, Rameau A, Sher D, Starmer H, Strohl M, Ulmer K, Vaitaitis V, Begum S, Batjargal M, Dhepyasuwan N. Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer Patients. Otolaryngol Head Neck Surg 168(4):571-592, 2023. PMID: 36965195.
Wang JH, Salama V, McCoy L, Dede C, Ajayi T, Moreno A, Mohamed ASR, Hutcheson KA, Fuller CD, van Dijk LV, MD Anderson Head and Neck Symptom Working Group. Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation. Radiother Oncol 180:109465, 2023. e-Pub 2023. PMID: 36640945.
Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, MD Anderson Head and Neck Cancer Symptom Working Group. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Med 12(4):5088-5098, 2023. e-Pub 2022. PMID: 36229990.
Aggarwal P, Nader ME, Gidley PW, Pratihar R, Jivani S, Garden AS, Mott FE, Goepfert RP, Ogboe CW, Charles C, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Hutcheson KA, Shete S. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med 12(1):569-583, 2023. e-Pub 2022. PMID: 35695117.
Watson LJ, Woodman SH, Ganderton D, Hutcheson KA, Pringle S, Patterson JM. Development of the remote 100 ml Water Swallow Test versus clinical assessment in head and neck cancer patients: do they agree?. Head & Neck 44(12):2769-2778, 2022. PMID: 36114683.
Contrera KJ, Zafereo ME, Yaniv D, Roberts DB, Gillenwater AM, Hanna EY, Weber RS, Myers JN, Chang EI, Garvey PB, Hanasono MM, Yu P, Hutcheson KA, Fuller CD, Tyler MA, Neskey DM. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol 134:106127, 2022. e-Pub 2022. PMID: 36155359.
Das P, Maiti R, Komal M, Hutcheson KA, Fuller CD, Chakraborty B, Peterson C. Estimating the optimal linear combination of predictors using spherically constrained optimization. Biometrics, 2022. PMID: 36261805.
Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):1945998211059967, 2022. e-Pub 2021. PMID: 34784256.
Barbon CEA, Peterson CB, Moreno AC, Lai SY, Reddy JP, Sahli A, Martino R, Johnson FM, Fuller CD, Hutcheson KA. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia. JAMA Otolaryngol Head Neck Surg. e-Pub 2022. PMID: 36074459.
Martino R, Khan M, Fitch M, Manduchi B, Rodriguez V, Hutcheson KA, Barbon C, McMillan H. Exploring Patient Experiences with a Telehealth Approach for the PRO-ACTIVE Trial Intervention in Head and Neck Cancer Patients. BMC Health Services Research 22(1):1218, 2022. PMID: 36180905.
Wang JH, McCoy L, Salama V, Ajayi T, Dede C, Moreno A, Mohamed AS, Hutcheson KA, Fuller CD, van Dijk, LV. Dysphagia and shortness-of-breath symptoms as markers for treatment failure and survival in oropharyngeal cancer patients. Radiotherapy and Oncology, 2022.
Aggarwal P, Hutcheson KA, Yu R, Wang J, Fuller CD, Garden AS, Goepfert RP, Rigert J, Mott FE, Lu C, Lai SY, Gunn GB, Chambers MS, Li G, Wu CC, Hanna EY, Sturgis EM, Shete S. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Scientific Reports, 2022. PMID: 35459784.
Ding Y, Meheissen MAM, Zhou K, Mohamed ASR, Wen Z, Ping NG S, Elhalawani, HM, Elgohari BA, Hutcheson, KA, Chung C, Lai SY, Fuller CD. Evaluation of different diffusion-weighted image techniques for head and neck radiation treatment: phantom and volunteer studies. Practical Radiation Oncology, 2022.
McMillan H, Barbon CEA, Cardoso R, Sedory A, Buoy S, Porsche C, Savage K, Mayo L, Hutcheson KA. Manual Therapy for Patients with Radiation-Associated Trismus after Head and Neck Cancer: A Case Series. JAMA Otolaryngology. e-Pub 2022. PMID: 35297966.
Aggarwal P, Hutcheson KA, Goepfert RP, Garden AS, Garg N, Mott FE, Fuller CD, Lai SY, Gunn GB, Chambers MS, Hanna EY, Sturgis EM, Shete S. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck. e-Pub 2022. PMID: 35084077.
Martino R, Fitch MI, Fuller CD, Hope AJ, Krisciunas GP, Lanmore S, Lazarus C, Macdonald CL, McCulloch TM, Mills G, Palma D, Pytynia KB, Ringash J, Sultanem K, Theurer J, Thorpe KE, Hutcheson KA. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVention for patients receiving radiotherapy for head and neck cancer. BMC Cancer 21, 2021. PMID: 34645411.
Bahig H, Gunn GB, Garden AS, Ye R, Hutcheson KA, Rosenthal DI, Phan J, Fuller DC, Morrison WH, Reddy JP, NG SP, Gross ND, Sturgis EM, Ferrarotto R, Gillison M, Frank SJ. Patient-reported Outcomes after Oropharynx Intensity Modulated Proton Therapy using Functional Assessment of Cancer Therapy-Head and Neck Instrument. International Journal of Particle Therapy 1:213-222, 2021. PMID: 34285948.
Starmer H, Arrese L, Langmore S, Ma Y, Murray J, Patterson J, Pisegna J, Roe J, Tabor-Gray L, Hutcheson KA. Adaptation and Validation of the Dynamic Imaging Grade of Swallowing Toxicity for Flexible Endoscopic Evaluation of Swallowing DIGEST FEES. Journal of Speech, Language, and Hearing Research 64(6):1802-1810, 2021. PMID: 34033498.
Elhalawani H, Cardena CE, Volpe S, Barua S, Stieb S, Rock C, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallag LE, Jethanandani Am, Mohamed ASR, Court LE, Hutcheson KA, Gunn GB, Rosenthal DI, Frank S, Garden AS, Rao A, Fuller CD. 18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer. Clinical and Translational Radiation Oncology 29:93-101, 2021. PMID: 34195391.
Barbon CEA, Yao CMKL, Alvarez CP, Goepfert RP, Fuller CD, Lai SY, Gross ND, Hutcheson KA. Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis. Head Neck. e-Pub 2021. PMID: 34080249.
Gunn GB, Garden AS, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Goepfert RP, Duvall A, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Shete S. Association of Risk Factors with Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2021. PMID: 33956062.
van Dijk LV, Abusaif AA, Rigert J, Naser MA, Hutcheson KA, Lai SY, Fuller CD, Mohamed ASR, on behalf on the MD Anderson Symptom Working Group. Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort. Int J Radiat Oncol Biol Phys. e-Pub 2021. PMID: 33965514.
Hernandez M, Lee JJ, Yap B, Ye R, Foote RL, Busse P, Patel SH, Dagan R, Snider J, Mohammed N, Lin A, Blanchard P, Cantor SB, Teferra MY, Hutcheson KA, Yepes P, Mohan R, Liao Z, DeLaney T, Frank SJ. The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial. Advances in Radiation Oncology, 2021. PMID: 33732960.
Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed AS, Fuller CD, Lai SY, Rao A. Computed Tomography radiomics kinetics as early imaging correlates of osteoradionecrosis in oropharyngeal cancer patients. Frontiers Artificial Intelligence 9(4), 2021. PMID: 33898983.
Bahig H, Rosenthal DI, Nguyen-Tan FP, Fuller DC, Yuan Y, Hutcheson KA, Christopoulos A, Nichols AC, Fung K, Ballivy O, Filion E, Ng SP, Lambert L, Dorth J, Hu KS, Palma D. Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial. BMC Cancer 21(1):446, 2021. e-Pub 2021. PMID: 33888069.
van Dijk LV, Mohamed ASR, Ferrarotto R, McCoy LA, Sharafi CS, Jones E, Steele K, Moreno AC, Lai SY, Garden AS, Myers JN, Rosenthal DI, Fuller CD, Hutcheson KA, for MD Anderson Symptom Working Group. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry. Cancer. e-Pub 2021. PMID: 33788956.
Aggarwal P, Goepfert RP, Garden AS. Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngology, 2021. PMID: 33538759.
Wahid K, He R, McDonald BA, Anderson BA, Salzillo T, Mulder S, Wang J, Sharafi CS, McCoy L, Naser MA, Ahmed S, Sanders KL, Mohamed ASR, Ding Y, Wang J, Hutcheson KA, Lai SY, Fuller CD, can Dijik LV. MRI Intensity Standardization Evaluation Design for Head and Neck Quantitative Imaging Applications. Medrxiv, 2021.
Scott SI, Kathrine Ø Madsen A, Rubek N, Charabi BW, Wessel I, Fredslund Hadjú S, Jensen CV, Stephen S, Patterson JM, Friborg J, Hutcheson KA, Kehlet H, von Buchwald C. Long-term Quality of Life & Functional Outcomes After Treatment of Oropharyngeal Cancer. Cancer Med. e-Pub 2020. PMID: 33277795.
Yao CMKL, Hutcheson KA. Quality of Life Implications After Transoral Robotic Surgery for Oropharyngeal Cancer. Otolaryngol Clin North Am 53(6):1117-1129, 2020. e-Pub 2020. PMID: 32917421.
Mott FE, Sacks RL, Johnson FM, Hutcheson, KA, Gallagher NA, Varghese S, Zaveri J. Subjective Functional Outcomes in Oropharyngeal Cancer Treated with Induction Chemotherapy using the MD Anderson Symptom Inventory (MDASI). Laryngoscope Investigative Otolaryngology 6(5):1104-1109, 2020. PMID: 33364400.
Dahlstrom KR, Song J, Thall PF, Fuller CD, Hutcheson KA, Johnson FM, Gunn GB, Phan J, Frank SJ, Morrison WH, Ferrarotto R, Rosenthal DI, Sturgis EM, Garden AS. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. e-Pub 2020. PMID: 33306202.
Wilke C, Takiar V, Wang H, Moreno AC, Tung SS, Quinlan-Davidson SR, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Wang C, Zhao G, Hutcheson KA, Phan J. Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT. J Appl Clin Med Phys. e-Pub 2020. PMID: 33277960.
Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Phan J, Cardenas C, Ferrarotto R, Frank SJ, Rosenthal DI, Garden AS. Patterns of Failure After Intensity Modulated Radiation Therapy in Head and Neck Squamous Cell Carcinoma of Unknown Primary: Implication of Elective Nodal and Mucosal Dose Coverage. Adv Radiat Oncol 5(5):929-935, 2020. e-Pub 2020. PMID: 33083655.
Hutcheson KA, Gomes A, Rodriguez V, Barringer D, Khan M, Martino R. Eat All Through Radiation Therapy (EAT-RT): Structured therapy model to facilitate continued oral intake through head and neck radiotherapy-User acceptance and content validation. Head Neck 42(9):2390-2396, 2020. e-Pub 2020. PMID: 32445231.
Cardoso RC, Kamal M, Zaveri J, Chambers MS, Gunn GB, Fuller CD, Lai SY, Mott FE, McMillan H, Hutcheson KA. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center. Support Care Cancer. e-Pub 2020. PMID: 32779007.
Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective Longitudinal Patient-Reported Outcomes of Swallowing Following Intensity Modulated Proton Therapy for Oropharyngeal Cancer. International Journal of Radiation Oncology • Biology • Physics, 2020. e-Pub 2020. PMID: 32361662.
van Diks L, Ventura JD, Wahid, KA, Z LL, Mcdonald B, Ahmed SM, Sanders K, Stieb SM, McCoy LA, Sharafi CS, Preston KE, Ding Y, Wang J, Rigaud BS, Sen A, Chambers MS, Hutcheson KA, Brock K, Lai SY, Mohamed ASR. Black bone MRI morphometry for mandibular cortical bone measurement in head and neck cancer patients: a method comparison with CT. Radiology, 2020.
Jomaa MK, Crosby R, Grant S, Granberry RC, O'Donnel B, Dursteler A, Warren BW, Volpe S, Al Feghali K, Cardenas CE, Cardoso R, Lai SY, Radwan AS, Fuller CD, Hutcheson KA. Dose-Volume correlates of the prevalence of patient-reported trismus in long-term survivorship after oropharyngeal IMRT: A cross-sectional dosimetric analysis. Radiotherapy and Oncology:142-149, 2020. e-Pub 2020. PMID: 32387489.
Ferrarotto R, Bell D, Rubin ML, Hutcheson KA, Johnson JM, Goepfert RP, Phan J, Elamin YY, Torman Karagiannis DT, Warneke CL, Hessel AC, Garden AS, Myers JN, Johnson FM, Lee JJ, Sikora A, Gillison ML, Glisson BS, Gross ND. Impact of neoadjuvant durvalumab with or without tremelimumab on CD8+ tumor lymphocyte density, safety, and efficacy in patients with oropharynx cancer: CIAO trial. Clin Cancer Res. e-Pub 2020. PMID: 32269052.
Maniakas A, Jozaghi Y, Zafereo ME, Sturgis EM, Su SY, Gillenwater AM, Gidley PW, Lewis CM, Diaz E, Goepfert RP, Kupferman ME, Gross ND, Hessel AC, Pytynia KB, Nader ME, Wang JR, Lango MN, Kiong KL, Guo T, Zhao X, Yao CMKL, Appelbaum E, Alpard J, Garcia JA, Terry S, Flynn JE, Bauer S, Fournier D, Burgess CG, Wideman C, Johnston M, You C, De Luna R, Joseph L, Diersing J, Prescott K, Heiberger K, Mugartegui L, Rodriguez J, Zendehdel S, Sellers J, Friddell RA, Thomas A, Khanjae SJ, Schwarzlose KB, Chambers MS, Hofstede TM, Cardoso RC, Aponte Wesson R, Won A, Otun AO, Gombos DS, Al-Zubidi N, Hutcheson KA, Gunn GB, Rosenthal DI, Gillison ML, Ferrarotto R, Weber RS, Hanna EY, Myers JN, Lai SY. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. e-Pub 2020. PMID: 32342541.
Garden AS, Kamal MJ, Mohamed AR, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Ferrarotto R, Rosental DI, Hutcheson KA, Fuller CD, Gunn GB. Neurologic Sequelae of Treatment of Oropharyngeal Cancer: A Patient Reported Outcomes Study. Journal of Clinical Oncology, 2020. PMID: 32212359.
Jomaa M, Fuller CD, Gunn GB, Hutcheson KA, Mohamed ASR, Peeler CR, Cardenas CE, Yepes P, Amit J, Frank SJ, Mirkovic D, Blanchard P, Chen L, Breiner B, Mehta VN. Radiation-induced hypothyroidism after radical intensity-modulated radiation therapy for oropharyngeal carcinoma. Advances in Radiation Oncology 5(1):111-119, 2020. PMID: 32051897.
Townes TG, Navuluri S, Pytynia KB, Gunn GB, Kamal MJ, Gilmore KR, Chapman PH, Bell KV, Fournier DM, Janik MA, Joseph LM, Zendehdel S, Hutcheson KA, Goepfert RP. Assessing Patient-Reported Symptom Burden of Long-Term Head and Neck Cancer Survivors at Annual Surveillance in Survivorship Clinic. Head Neck. e-Pub 2020. PMID: 32112621.
He R, Ding Y, Mohamed ASR, Ng SP, Ger RB, Elhalawani H, Elgohari BA, Young KH, Hutcheson KA, Fuller CD, Lai SY. Simultaneously spatial and temporal higher-order total variations for noise suppression and motion reduction in DCE and IVIM. Proc SPIE Int Soc Opt Eng 11313, 2020. e-Pub 2020. PMID: 32753776.
Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: comparison with conventional radiation. Laryngoscope 130(1):1-8, 2020. e-Pub 2019. PMID: 30756394.
Yang J, Mohamed ASR, Bahig H, Ding Y, Wang J, Ng SP, Lai S, Miller A, Hutcheson KA, Fuller CD, Joint Head and Neck Radiotherapy MRI Development Cooperative. Automatic registration of 2D MR cine images for swallowing motion estimation. PLOS One 15(2):e0228652, 2020. e-Pub 2020. PMID: 32045464.
Check DK, Hutcheson KA, Poisson LM, Pocobelli G, Sakoda LC, Zaveri J, Chang SS, Chubak J. Factors associated with employment discontinuation among older and working age survivors of oropharyngeal cancer. Head Neck 41(11):3948-3959, 2019. e-Pub 2019. PMID: 31490588.
Hutcheson KA, Warneke CL, Yao CMKL, Zaveri J, Elgohari BE, Goepfert R, Hessel AC, Kupferman ME, Lai SY, Fuller CD, Gunn GB, Garden AS, Johnson F, Ferrarotto R, Lewin JS, Gross ND, MD Anderson Head and Neck Cancer Symptom Working Group. Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg 145(11):1053-1063, 2019. PMID: 31556933.
Aggarwal P, Zaveri JS, Goepfert RP, Shi Q, Du XL, Swartz M, Lai SY, Fuller CD, Lewin JS, Piller LB, Hutcheson KA. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head Neck. e-Pub 2019. PMID: 31441572.
Pocobelli G, Ziebell R, Fujii M, Hutcheson KA, Chang S, McClure JB, Chubak J. Symptom Burden in Long-Term Survivors of Head and Neck Cancer: Patient-Reported Versus Clinical Data. EGEMS (Wash DC) 7(1):25, 2019. e-Pub 2019. PMID: 31328132.
Omari T, Ciucci M, Gozdzikowska K, Hernandez E, Hutcheson K, Jones C, Maclean J, Nativ-Zeltzer N, Plowman E, Rogus-Pulia N, Rommel N, O'Rourke A. High resolution pharyngeal manometry: protocols and metrics recommendations of the high resolution pharyngeal manometry international working group. Dysphagia, 2019. PMID: 31168756.
Christopherson K, Ghosh A, Mohamed ASR, Jomaa MK, Gunn B, Marai CE, Canahuate G, El Halawani H, Vock D, Kalpathy-Cramer J, Dale T, Messer J, Garden AS, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Gross N, Ferrarotto R, Weber RS, Rosenthal DI, Hutcheson KA, Fuller D. Chronic Radiation-Associated Dysphagia in Oropharyngeal Cancer Survivors: Towards Age-Adjusted Dose Constraints for Deglutitive Muscles. Clinical and Translationsal Radiation Oncology, 2019. PMID: 31341972.
Wang JR, Nurgalieva Z, Fu S, Tam S, Zhao H, Giordano SH, Hutcheson KA, Lewis CM. Utilization of rehabilitation services in patients with head and neck cancer in the United States: A SEER-Medicare analysis. Head Neck. e-Pub 2019. PMID: 31240808.
Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer 125(10):1654-1664, 2019. PMID: 30633325.
Kamal M, Rosenthal DI, Batra AD, Volpe S, Elgohari B, Goepfert RP, Garden AS, Hutcheson KA, Phan J, Eraj S, Dursteler A, Williams B, Smith J, Aymard J, Berends J, White A, Cardenas CE, Frank SJ, Morrison WH, Sturgis EM, Mendoza TR, Mohamed AS, Fuller CD, Gunn GB. Fatigue Following Radiation Therapy in Nasopharyngeal Cancer Survivors: A Dosimetric Analysis Incorporating Patient Report and Observer Rating. International Journal of Radiation Oncology 102(3):749-750, 2019. PMID: 30935579.
Krisciunas GP, Vakharia A, Lazarus C, Taborda SG, Martino R, Hutcheson KA, McCulloch T, Langmore S. Application of manual therapy for dysphagia in head and neck cancer patients: a preliminary national survey of treatment trends and adverse events. Global Advances in Health and Medicine 8, 2019. PMID: 31041144.
Massarelli E, Haddad RI, Lee JJ, Lin HY, Hutcheson KA, Lewis J, Garden AS, Blumenschein Jr GR, William Jr, WN, Pharaon RR, Tishler RB, Glisson BS, Gold KA, Johnson FM, Rabinowits G, Ginsberg LE, Williams MD, Myers JN, Kies MS, Papadimitrakopoulou V. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by risk-based local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Annals of Oncology, 2019. PMID: 30596812.
Hutcheson KA, Gomes A, Rodriguez V, Barringer D, Khan M, Martino R. EAT All Through Radiation Therapy (EAT-RT): Structured therapy model to facilitate continued oral intake through head and neck radiotherapy- User acceptance and content validation. Dysphagia 34:944-1018, 2019. PMID: 32445231.
Hutcheson KA, Nurgalieva Z, Zhao H, Gunn GB, Giordano SH, Bhayani MK, Lewin JS, Lewis CM. Two-year prevalence of dysphagia and related outcomes in head and neck cancer survivors: An updated SEER-Medicare analysis. Head Neck 41(2):479-487, 2019. e-Pub 2018. PMID: 30536748.
Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow M, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, WAng XS, Fuller CD, Hutcheson KA. Single item discrimination of quality of life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: comparison of patient-reported outcomes measures of swallowing. Cancer. e-Pub 2019. PMID: 30633325.
Meheissen MAM, Mohamed ASR, Kamal M, Hernandez M, Volpe S, Elhalawani H, Barrow MP, Ding Y, Wang J, Davuluri R, Rostom Y, Hegazy N, Gunn GB, Lai SY, Garden AS, Lewin JS, Rosenthal DI, Frank SJ, Fuller CD, Hutcheson KA, Joint Head and Neck Radiotherapy-MRI Development Cooperative. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial. Radiotherapy and Oncology, 2019. PMID: 30206020.
Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope 127(4):842-848, 2017. e-Pub 2016. PMID: 27440393.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai SY, Gross ND, Schwartz DL, Hutcheson KA. Long-term prospective performance of the M. D. Anderson Dysphagia Inventory in "low-intermediate risk" oropharyngeal carcinoma after intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 97(4):700-708, 2017. e-Pub 2016. PMID: 27485284.
Sheu T, Vock D, Gross N, Mulcahy C, Zafereo M, Gunn G, Garden A, Sevak P, Phan J, Lewin J, Frank S, Beadle B, Morrison W, Lai S, Hutcheson KA, Marai GE, Canahuate GM, Kies M, El-Naggar A, Weber R, Rosenthal D, Fuller CD, Multidisciplinary Larynx Cancer Working Group. Conditional survival analysis of patients with locally advanced laryngeal cancer: construction of a dynamic risk model and clinical nomogram. Sci Rep 7:43928, 2017. e-Pub 2017.
Hutcheson KA, Barrow MP, Barringer DA, Knott JK, Lin HY, Weber RS, Fuller CD, Lai SY, Alvarez CP, Raut J, Lazarus CL, May A, Patterson J, Roe JW, Starmer HM, Lewin JS. Dynamic imaging grade of swallowing toxicity (DIGEST): scale development and validation. Cancer 123(1):62-70, 2017. e-Pub 2016. PMID: 27564246.
Somogyi-Ganss E, Chambers MS, Lewin JS, Tarrand JJ, Hutcheson KA. Biofilm on the tracheoesophageal voice prosthesis: considerations for oral decontamination. Eur Arch Otorhinolaryngol 274(1):405-413, 2017. e-Pub 2016. PMID: 27400694.
Chen DW, Lewin JS, Xu L, Lai SY, Gunn GB, Fuller CD, Mohamed AS, Kanwar A, Sturgis EM, Hutcheson KA. Feeding tube utilization in patients with salivary gland malignancies. Otolaryngol Head Neck Surg 156(1):109-117, 2017. e-Pub 2016. PMID: 27576681.
Lewin JS, Baumgart LM, Barrow MP, Hutcheson KA. Device life of the tracheoesophageal voice prosthesis revisited. JAMA Otolaryngol Head Neck Surg 143(1):65-71, 2017. e-Pub 2016. PMID: 27684464.
Beadle BM, Liao KP, Giordano SH, Garden AS, Hutcheson KA, Lai SY, Guadagnolo BA. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Cancer 123(2):283-293, 2017. e-Pub 2016. PMID: 27662641.
Gitomer SA, Hutcheson KA, Christianson BL, Samuelson MB, Barringer DA, Roberts DB, Hessel AC, Weber RS, Lewin JS, Zafereo ME. Influence of timing, radiation, and reconstruction on complications and speech outcomes with tracheoesophageal puncture. Head Neck 38(12):1765-1771, 2016. e-Pub 2016. PMID: 27394060.
Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of head and neck cancers with proton therapy: outcomes and analyses. Int J Radiat Oncol Biol Phys 96(1):30.41, 2016. e-Pub 2016. PMID: 27325480.
Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. PMID: 27342249.
Hutcheson KA, Abualsamh AR, Sosa A, Weber RS, Beadle BM, Sturgis EM, Lewin JS. Impact of selective neck dissection on chronic dysphagia after chemo-intensity-modulated radiotherapy for oropharyngeal carcinoma. Head Neck 38(6):886-893, 2016. e-Pub 2015. PMID: 26339764.
Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol 57:1-5, 2016. e-Pub 2016. PMID: 27208837.
Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Association of body composition with survival and locoregional control of radiotherapy-treated head and neck squamous cell carcinoma. JAMA Oncol 2(6):782-9, 2016. PMID: 26891703.
Hutcheson KA, Barrow MP, Lisec A, Barringer DA, Gries K, Lewin JS. What is a clinically relevant difference in MDADI scores between groups of head and neck cancer patients?. Laryngoscope 126(5):1108-13, 2016. e-Pub 2015. PMID: 26542529.
Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 95(1):360-7, 2016. e-Pub 2016. PMID: 27084653.
Lewis CM, Aloia TA, Shi W, Martin I, Lai SY, Selber JC, Hessel AC, Hanasono MM, Hutcheson KA, Robb GL, Weber RS. Development and feasibility of a specialty-specific national surgical quality improvement program (NSQIP): The head and neck-reconstructive surgery NSQIP. JAMA Otolaryngol Head Neck Surg 142(4):321-327, 2016. e-Pub 2016. PMID: 26892756.
Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity-modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 2016. e-Pub 2015. PMID: 25994561.
Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2016. e-Pub 2016. PMID: 26830697.
Dale T, Hutcheson KA, Mohamed, AS, Lewin JS, Gunn GB, Rao AU, Kalpathy-Cramer J, Frank SJ, Garden AS, Messer JA, Warren B, Lai SY, Morrison WH, Phan J, Skinner H, Gross N, Ferrarotto R, Weber R, Rosenthal DI, Fuller CD. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol 118(2):304-314, 2016. e-Pub 2016. PMID: 26897515.
Sandulache VC, Hobbs BP, Mohamed ASR, Frank SJ, Song J, Ding Y, Kalpathy-Cramer J, Hazle JD, Wang J, Awan M, Rosenthal DI, Garden AS, Gunn GB, Colen RR, El-shafeey N, El-banan M, Hutcheson KA, Lewin J, Chambers MS, Hofstede T, Weber RS, Lai SY, Fuller CD. Dynamic contrast-enhanced MRI detects acute radiotherapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. Sci Rpt 6:29864, 2016. e-Pub 2016. PMID: 27499209.
Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-138, 2015. e-Pub 2015. PMID: 26403258.
Owadally W, Hurt C, Timmins H, Parsons E, Townsend S, Patterson J, Hutcheson KA, Powerll N, Beasley M, Palaniappan N, Robinson M, Jones TM, Evans M. PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV) - positive oropharyngeal cancer. BMC Cancer 15(1):602, 2015. PMID: 26311526.
Holliday EB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Gunn BG, Phan J, Beadle BM, Zhu XR, Zhang X, Hanna E, Glisson BS, Hutcheson KA, El-Naggar AK, Hong J, Hung T, Uzel EK, Lewis G, Frank SJ. Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy. IJPT 2(1):19-28, 2015.
Hutcheson KA, Yuk MM, Holsinger FC, Gunn GB, Lewin JS. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy in long-term oropharyngeal cancer survivors: video case reports. Head Neck 37(4):E56-62, 2015. e-Pub 2014. PMID: 25043608.
Hutcheson KA, Holsinger FC, Kupferman ME, Lewin JS. Functional outcomes after TORS for oropharyngeal cancer: A systematic review. Eur Arch Otorhinolaryngol 272(2):463-471, 2015. e-Pub 2014. PMID: 24643851.
Smith BG, Hutcheson KA, Little LG, Skoracki RJ, Rosenthal DI, Lai SY, Lewin JS. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg 152(2):284-291, 2015. e-Pub 2014. PMID: 25389318.
Setton J, Lee NY, Riaz N, Huang SH, Waldron J, O'Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy. Cancer 121(2):294-301, 2015. e-Pub 2014. PMID: 25286832.
Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: A preliminary dosimetric comparison. Oral Oncol 50(8):746-52, 2014. e-Pub 2014. PMID: 24906528.
Lewin JS, Portwood MA, Wang Y, Hutcheson KA. Clinical application of the Provox NiD voice prosthesis: A longitudinal study. Laryngoscope 124(7):1585-1591, 2014. e-Pub 2013. PMID: 24352975.
Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975-84, 2014. e-Pub 2014. PMID: 24711162.
Hutcheson KA, Lewin JS, Holsinger FC, Steinhaus G, Lisec A, Barringer DA, Lin HY, Villalobos S, Garden AS, Papadimitrakopoulou V, Kies MS. Long-term functional and survival outcomes after induction chemotherapy and risk-based definitive therapy for locally advanced squamous cell carcinoma of the head and neck. Head Neck 36(4):474-80, 2014. e-Pub 2013. PMID: 23780650.
Shinn EH, Basen-Engquist K, Baum G, Steen S, Bauman RF, Morrison W, Garden AS, Sheil C, Kilgore K, Hutcheson KA, Barringer D, Yuan Y, Lewin JS. Adherence to preventive exercises and self-reported swallowing outcomes in post-radiation head and neck cancer patients. Head Neck 35(12):1707-12, 2013. e-Pub 2013. PMID: 24142523.
Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Alvarez CP, Roberts DB, Lai SY, Lewin JS. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: Factors affecting placement and dependence. Head Neck 35(11):1641-1646, 2013. e-Pub 2013. PMID: 23322563.
Hutcheson KA, Bhayani MK, Beadle BM, Gold KA, Shinn EH, Lai SY, Lewin J. Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it. JAMA Otolaryngol Head Neck Surg 139(11):1127-34, 2013. PMID: 24051544.
Fingeret MC, Hutcheson KA, Jensen K, Yuan Y, Urbauer D, Lewin JS. Associations among speech, eating, and body image concerns for surgical patients with head and neck cancer. Head Neck 35(3):354-360, 2013. e-Pub 2012. PMID: 22431304.
Raol N, Hutcheson KA, Lewin JS, Kupferman ME. Surgical management of the non-functional larynx after organ preservation therapy. J Otol Rhinol 2(1), 2013.
Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn GB, Moore MW, Holsinger FC. Late dysphagia after radiotherapy-based treatment of head and neck cancer. Cancer 118(23):5793-5799, 2012. e-Pub 2012. PMID: 23640737.
Hutcheson KA, Jantharapattana K, Barringer DA, Lewin JS, Holsinger FC. Functional and oncological outcomes of primary versus salvage transoral laser microsurgery for supraglottic carcinoma. Ann Otol Rhinol Laryngol 121(10):664-70, 2012. PMID: 23130541.
Hutcheson KA, Sturgis EM, Lewin JS. Early risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy: Nodal metastasis and extent of surgery. Arch Otolaryngol Head Neck Surg 138(9):833-839, 2012. e-Pub 2012. PMID: 22911245.
Lewin JS, Hutcheson KA, Barringer DA, Croegaert LE, Lisec A, Chambers MS. Customization of the voice prosthesis to prevent leakage from the enlarged tracheoesophageal puncture: Results of a prospective trial. Laryngoscope 122(8):1767-1772, 2012. e-Pub 2012. PMID: 22753122.
Kim HN, Lewin JS, Knott JK, Hutcheson KA, Dekovich AA. Novel therapeutic approach to relieve pharyngoesophageal spasm after total laryngectomy. Gastrointest Endosc 76(1):193-196, 2012. PMID: 22726482.
Hutcheson KA, Lewin JS, Sturgis EM, Risser J. Multivariable analysis of risk factors for enlargement of the tracheoesophageal puncture after total laryngectomy. Head Neck 34(4):557-567, 2012. e-Pub 2011. PMID: 21692129.
Hutcheson KA, Alvarez CP, Barringer DA, Kupferman ME, Lapine PR, Lewin JS. Outcomes of elective total laryngectomy for laryngopharyngeal dysfunction in disease-free head and neck cancer survivors. Otolaryngol Head Neck Surg 146(4):585-590, 2012. e-Pub 2012. PMID: 22235071.
Shuaib SW, Hutcheson KA, Knott JK, Lewin JS, Kupferman ME. Minimally-invasive approach for the management of the leaking tracheoesophageal puncture. Laryngoscope 122(3):590-4, 2012. e-Pub 2012. PMID: 22252440.
Kupferman ME, Acevedo J, Hutcheson KA, Lewin JS. Addressing an unmet need in oncology patients: rehabilitation of upper aerodigestive tract function. Ann Oncol 22(10):2299-2303, 2011. e-Pub 2011. PMID: 21321090.
Hutcheson KA, Lewin JS, Sturgis EM, Risser J. Outcomes and adverse events of enlarged tracheoesophageal puncture after total laryngectomy. Laryngoscope 121(7):1455-1461, 2011. e-Pub 2011. PMID: 21647906.
Hutcheson KA, Lewin JS, Sturgis EM, Kapadia A, Risser J. Enlarged tracheoesophageal puncture after total laryngectomy: A systematic review and meta-analysis. Head Neck 33(1):20-30, 2011. e-Pub 2010. PMID: 20848420.
Moreno MA, Lewin JS, Hutcheson KA, Bishop Leone JK, Barringer DA, Reece GP. Tracheostomaplasty: A surgical method for improving retention of an intraluminal stoma button for hands-free tracheoesophageal speech. Head Neck 32(12):1674-1680, 2010. e-Pub 2010. PMID: 20848405.
Schwartz DL, Hutcheson KA, Barringer DA, Tucker SL, Kies MS, Holsinger FC, Ang KK, Morrison WH, Rosenthal DI, Garden AS, Dong L, Lewin JS. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 78(5):1356-1365, 2010. e-Pub 2010. PMID: 20646872.
Tirado Y, Lewin JS, Hutcheson KA, Kupferman ME. Office-based injection laryngoplasty in the irradiated larynx. Laryngoscope 120(4):703-6, 2010. PMID: 20205170.
LeBert B, McWhorter AJ, Kunduk M, Walvekar RR, Lewin JS, Hutcheson KA, Barringer DA, Hessel AC, Holsinger FC. Secondary tracheoesophageal puncture with in-office transnasal esophagoscopy. Arch Otolaryngol Head Neck Surg 135(12):1190-4, 2009. PMID: 20026814.
Lewin JS, Montgomery PC, Hutcheson KA, Chambers MS. Further experience with modification of an intraluminal button for hands-free tracheoesophageal speech after laryngectomy. J Prosthet Dent 102(5):328-31, 2009. PMID: 19853175.
Davie GL, Hutcheson KA, Barringer DA, Weinberg JS, Lewin J. Aphasia in patients after brain tumor resection. Aphasiology 23(9):1196-1206, 2009.
Barringer DA, Hutcheson KA, Sturgis EM, Kies MS, Lewin JS. Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer. Head Neck 31(5):611-7, 2009. PMID: 19107949.
Lewin JS, Hutcheson KA, Barringer DA, May AH, Roberts DB, Holsinger FC, Diaz EM,. Functional analysis of swallowing outcomes after supracricoid partial laryngectomy. Head Neck 30(5):559-66, 2008. PMID: 18098304.
Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, Lewin JS. Swallowing outcomes after radiotherapy for laryngeal carcinoma. Arch Otolaryngol Head Neck Surg 134(2):178-83, 2008. PMID: 18283161.
Lewin JS, Barringer DA, May AH, Gillenwater AM, Arnold KA, Roberts DB, Yu P. Functional outcomes after laryngopharyngectomy with anterolateral thigh flap reconstruction. Head Neck 28(2):142-9, 2006. PMID: 16302192.
Lewin JS, Barringer DA, May AH, Gillenwater AM, Arnold KA, Roberts DB, Yu P. Functional outcomes after circumferential pharyngoesophageal reconstruction. Laryngoscope 115(7):1266-71, 2005. PMID: 15995519.
Mao, S, Hutcheson KA. Advancing MBS Pre-Sorting with Deep Learning: A New Paradigm for the First Step Analysis in X-ray Swallowing Study. Journal of Biomedical and Health Informatics.
Hurt, C, O'Hara, Joames, Ingarfield, K, Patterson, J, Hutcheson KA. Early post-operative functional outcomes following transoral surgery for human papilloma virus (HPV) related oropharyngeal carcinoma in a subset analysis of a randomised clinical trial – laser microsurgery versus robotic surgery. British Journal of Surgery.
Hutcheson KA. Suboptimal Diet Quality Among Oropharyngeal Cancer Survivors Across the Cancer Continuum: Findings from the U-DINE Study. Communications Medicine.

Invited Articles

Connelly K, Gurd L, Noll K, Prabhu S, Kumar V, Hutcheson KA. A Framework for Integrating Speech Language Pathology in an Interdisciplinary Awake Craniotomy Program for Brain Tumor Resection. Perspectives of The ASHA Special Interest Groups, 2022.
Arrese LC, Hutcheson KA. Framework for Speech-Language Pathology Services in Patients with Oral Cavity and Oropharyngeal Cancers. Oral Maxillofac Surg Clin North Am 30(4):397-410, 2018. PMID: 30266189.
Malandraki GA, Hutcheson KA. Intensive therapies for dysphagia: implementation of the intensive dysphagia rehabilitation and the M. D. Anderson bootcamp approach. ASHAWire, 2018.
Hutcheson KA. Developing a clinical question into a research question: the “use it or lose it” example. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) SIG 13(Volume 2, Part 4):147-154, 2017.
Ciucci M, Jones CA, Malandraki GA, Hutcheson KA. Dysphagia practice in 2035: beyond fluorography, thickener, and electrical Stimulation. Semin Speech Lang 37(3):201-18, 2016. e-Pub 2016. PMID: 27232095.
Cohen EE, LaMonte SJ, Erb NL, Beckman KL, Sadeghi N, Hutcheson KA, Stubblefield MD, Abbott DM, Fisher PS, Stein KD, Lyman GH, Pratt-Chapman ML. American Cancer Society Head and Neck Cancer Survivorship Care Guideline. CA Cancer J Clin 66(3):203-39, 2016. e-Pub 2016. PMID: 27002678.
Lewis CM, Hutcheson KA, Kupferman ME. Comparative effectiveness in head and neck malignancies. Cancer Treat Res 164:89-99, 2015. PMID: 25677020.
Hutcheson KA, Lewin JS. Functional assessment and rehabilitation - How to maximize outcomes. Otolaryngol Clin North Am 46(4):657-70, 2013. e-Pub 2013. PMID: 23910476.
Hutcheson, KA. Late radiation-associated dysphagia (RAD) in head and neck cancer survivors. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) 22(2):61-72, 2013. e-Pub 2013.
Hutcheson KA, Lewin JS. Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers. Curr Oncol Rep 14(2):158-165, 2012. PMID: 22249533.
Lewin JS, Hutcheson KA, Barringer DA, Smith BS. Preliminary experience with head and neck lymphedema and swallowing function in patients treated for head and neck cancer. Perspectives on Swallowing and Swallowing Disorders (Dysphagia) 19(2):45-52, 2010.
Bhayani, Mihir. To Flap or Not to Flap: Considerations in Salvage Laryngectomy Reconstruction. JAMA Otolaryngology-Head & Neck Surgery.

Abstracts

Hutcheson KA; Appana, SN; Tark, JY; Li, R; Sharma, SV; Satach, C; Roller, E; Sandulache, V; de Oliveira. Exploring dietary quality and insufficiencies in relation to swallow function and symptoms among HPV-positive oropharyngeal cancer patients. 32nd Meeting of the Dysphagia Research Society, 2024.
Burdick, R., Wu, J., Aldridge, E., Terp, C., Gustafson, S., Warneke, C., Rogus-Pulia, N., Hutcheson KA. Does Standardized Inclusion of Thickened Liquids in a Modified Barium Swallow Bolus Protocol Affect DIGEST Scores?. 32nd Meeting of the Dysphagia Research Society. e-Pub 2024.
Gillison M, Williams M, Johnson J, Leung C, Reddy J, Garden A, Ferrarotto R, Mott F, Le X, Gunn G, Lee Am Fuller C, Moreno A, Hutcheson K, Gross N, Lango M, Goepfert R, Myers J, Hanna E, Xiao W, Rudqvist NP, Lee J, Phan J. Phase 2 trial of induction and concomitant CTLA4 (ipilimumab) and PD-1 (nivolumab) immune checkpoint blockade and intensity modulated radiation therapy (IMRT) in HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC). Journal for ImmunoTherapy of Cancer 10(2), 2022.
Hutcheson KA, Peterson C, Barbon CEA, Quon H, Mehra R, Ringash J, Lewin J, Flamand Y, Duvvuri U, Ozer E, Thomas G, Kupferman M, Kock W, Bell R, Saba N, Panwar A, Annino Jr D, Wagner L, Ferris R, Burtness B. Reduced aspiration rates for 50 Gy postoperative radiation in HPV-associated oropharynx cancer in E3311: a trial of the ECOG-ACRIN Cancer Research Group. Red Journal 114(3):S27-28, 2022.
He R, Wahid K, Mohamed A, McDonald B, Ding Y, Nasser M, Wang J, Hutcheson KA, Fuller CD, Lai SY. Koopman Theory-Based Dynamic Mode Decomposition for Dynamic Contrast-Enhanced HNC MRI Motion Correction. American Association of Physicists in Medicine, 2022.
Gilmore KR, Hutcheson KA, Chapman PH, Ryan WB, Goepfret R, Pytynia KB, Rodriguez MA,. Symptom Profile of Head and Neck Patients Initiating Care in a Survivorship Clinic 40(16):e2047, 2022.
McMillan H, Lewin JS, Cardoso R, Mayo L, Porsche C, Savage K, Barbon C, Buoy S, Hutcheson KA. Manual Therapy For Head And Neck Cancer Related Trismus: A Case Series. Jama Otolaryngol Head Neck Surg 148(5):418-425, 2022. PMID: 35297966.
Aggarwal P, Hutcheson KA, Garden AS, Mott F, Lu C, Goepfert RP, Fuller CD, Lai S, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete SS. Risk Factors of Patient-Reported Xerostomia Among Oropharyngeal Cancer Survivors Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 111(3S):e160, 2021. PMID: 34700812.
Wang J, McCoy L, Salama V, Dede C, Hutcheson KA, Fuller CD, van Dijk LV. Sub-Acute Post-Treatment Dysphagia and Shortness of Breath Symptoms Associate With Worse Survival in Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 111(3S):e400-e401, 2021. PMID: 34701366.
Barbon CE, Peterson CB, Fuller CD, Lai S, Moreno AC, Johnson FM, Hutcheson KA. Prospective Validation of the Use It or Lose It Paradigm: Secondary Analysis of Sub-Acute Dietary Outcomes by Eat and Exercise Status During Oropharyngeal Radiotherapy. Int J Radiat Oncol Biol Phys 111(3S):e408-e409, 2021. PMID: 34701381.
Aggarawal P, Goepfert RP, Garden AS, Garg N, Zaveri J, Du XL, Swartz M, Lai SY, Fuller CD, Ferrarotto R, Piller L, Hutcheson KA. Risk and Predictors of Late Lower Cranial Neuropathy In Long-Term Oropharyngeal Cancer Survivors: A Single Institution Retrospective Cohort Study Among 2,021 Survivors. Dysphagia, 2021. PMID: 33538759.
Williams L, Whisenant M, Mendoza TR, Malveaux D, Griffin D, Ponce D, Cleeland CS, Peek A, Granwehr BP, Hutcheson KA, Shaw KR, Ravi V, Woodman SC, Chung C, Aloia TA, Futreal PA, Jaffray DA, Subbiah IM. Development and validation of a novel patient reported outcomes measure for symptom burden in patients with cancer and COVID-19 infection 36(15):12113, 2021.
Deshpande TS, Gunn GB, Fuller CD, Ye R, Rosenthal DI, Garden AS, Morrison W, Phan J, Reddy J, Sturgis E, Lu C, Chambers M, Hutcheson K, Wang L, Zhang X, Zhu R, Stieb S, Foote R, Frank SJ. Erratum to: Xerostomia Impacts Dysgeusia in Oropharyngeal Cancer Patients Treated with Proton Therapy. International Journal of Radiation Oncology Biology and Physics:E414-E415, 2019.
Bahig H, Gunn GB, Garden AS, Rosenthal DI, Hutcheson KA, Phan J, Fuller CD, Reddy JP, Rong Y, Zaveri H, Ng SP, Weber RS, Myers JN, Gross ND, Sturgis EM, Lu C, Gillison ML, Frank SJ. Toxicity and Pharyngeal Dysphagia Outcomes from Intensity Modulated Proton Therapy for Oropharyngeal Squamous Cell Cancer. International Journal Radiation Oncology Biology Physics 105(1):E410, 2019.
Fitch M, Macdonald C, Hutcheson KA, McCulloch TM, Martino R. Engaging Stakeholders to Identify Relevant Outcomes For Dysphagia Interventions. Support Care Cancer:S168, 2019.
Hutcheson KA, Zaveri J, Lewin JS, Fuller CD, Gunn GB, Ferrarotto R, Yao C, Gross ND. Evolution of postsurgical dysphagia after TORS for oropharyngeal cancer: A prospective registry analysis. Jama Otolaryngol Head Neck Surg, 2019.
Hutcheson KA ,Warneke C, Alvarez C, Barrringer D, J Knott J, Lewin JS. Reliability of “Real-Time” Grading of Dysphagia Severity (per DIGEST) by Speech Pathologists Conducting Videofluoroscopic Swallow Studies. Jama Otolaryngol Head Neck Surg, 2019.
Hutcheson KA. Expiratory Muscle Strength Training (EMST) for Radiation-Associated Dysphagia (RAD): Results of a Pilot Prospective Trial. Dysphagia 34(6):995, 2019.
Elhalawani H, Volpe S, Cardenas CE, Barua S, Rock C, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, Mohamed AS, Hutcheson KA, Gunn GB, Rosenthal DI, Frank SJ, Garden AS, Rao A, Fuller CD. Development of Temporal Dose-Weighted Positron Emission Tomography Metabolic Imaging Biomarkers (PET MIBs) of Radiation-Related Parotid Glands Injury in Oropharyngeal Cancer Patients. International Journal of Radiation Oncology 102(3):240-241, 2018.
Elgohari B, Mohamed AS, Ng SP, Elhalawani H, Elsayes AK, He R, Ding Y, Wang J, Elawadi M, Awad I, Hutcheson KA, Gunn BG, Frank SJ, Garden AS, Rosenthal DI, Lai S, Fuller CD. Diffusion-Weighted MRI As an Early Biomarker of Xerostomia in Oropharyngeal Cancer Patients Treated with Radiation Therapy. International Journal of Radiation Oncology 102(3):214-215, 2018.
Aggarwal P, Zaveri J, Goepfert RP, Gunn GB, Lai S, Fuller CE, Hanna EY, Rosenthal DI, Lewin JS, Hutcheson KA. Functional Burden Associated with Late Lower Cranial Neuropathy in Long-Term Oropharyngeal Cancer Survivors Treated with Definitive Radiation Therapy. International Journal of Radiation Oncology 102(3):E408, 2018.
Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Eraj S, Dursteler A, Williams B, Smith J, Aymard J, Berends J, White A, O'Donnell B, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Cardenas CE, Skinner HD, Phan J, Mohamed AS, Fuller CD, Gunn GB. Patient-Reported Dry Mouth after Radiation Therapy for Head and Neck Cancer: Dosimetric Analysis of Long-Term Outcomes. International Journal of Radiation Oncology 102(3):e748, 2018.
Mohamed AS, Al Feghali KA, Ng SP, Elhalawani H, Hutcheson KA, Chambers MS, Phan J, Kraeima J, Glas H, Witjes M, Gunn GB, Garden AS, Rosenthal DI, Frank SJ, Morrison WH, Fuller CD, Lai S. Investigation of the Three-Dimensional Dose Distribution of Mandibular Areas of Origin of Advanced Osteoradionecrosis in Oropharyngeal Cancer Patients Receiving IMRT. International Journal of Radiation Oncology 102(3):E335-336, 2018.
Grant SR, Kamal M, Mohamed AS, Zaveri J, Barrow MP, Gunn GB, Lai S, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Patient-Reported Outcome Measures of Long-Term Swallowing Function after Oropharyngeal Radiation Therapy: A Cross-Sectional Methods Comparison. International Journal of Radiation Oncology 102(3):e221-e222, 2018.
Hutcheson KA, Ye R, Blanchard P, Gunn GB, Fuller CD, Lewin JS, Frank SJ. Two-Year Prospective Patient Reported Outcomes Related to Dysphagia After Intensity Modulated Proton Therapy for Oropharyngeal Cancer. International Journal of Radiation Oncology 100(5):1389, 2018.
Elhalawani H, Volpe S, Barua S, Mohamed A, Yang P, Ng SP, Lai S, Hutcheson KA, Gunn GB, Court LE, Rao A, Fuller CD. Exploration of an Early Imaging Biomarker of Osteoradionecrosis in Oropharyngeal Cancer Patients: Case-Control Study of the Temporal Changes of Mandibular Radiomics Features. International Journal of Radiation Oncology 100(5):1363-1364, 2018.
Ferrarotto R, Glisson BS, Bell D, Hutcheson KA, Phan J, Tran HT, Gibbs DL, Lee JJ, Gillison ML, Sikora AG, Gross ND. Checkpoint Inhibitors Assessment in Oropharynx Carcinoma (CIAO). J Clin Oncol 36(Suppl 5S, abstr TPS118), 2018.
Dursteler A, Kamal M, Mohamed ASR, Eraj S, Meheissen MAM, Garden AS, Sturgis EM, Hutcheson KA, Lu C, Mendoza TR, Frank SJ, Morrison WH, Rosenthal DI, Fuller CD. Gunn GB. Longitudinal assessment of chronic fatigue in oropharyngeal cancer patients after definitive radiation treatment. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E533, 2017.
Erajs S, Jomaa M, Rock CD, Mohamed ASR, Hutcheson KA, Sturgis EM, Lu C, Morrison WH, Rosenthal DI, Frank SJ, Garden AS, Fuller CD, Gunn GB. Long-term patient report outcomes following radiation therapy for early stage base of tongue carcinoma: a symptom assessment study. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E336, 2017.
Hutcheson KA, Nurgalieva Z, Gunn GB, Giordano S, Zhao H, Bhayani M, Lewis C.. 2-Year prevalence of dysphagia and related outcomes in head and neck cancer survivors: an updated SEER-Medicare analysis. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E342, 2017.
Kamal M, Dursteler A, O'Donnell BP, Eraj S, Mohamed ASR, Cardenas C, Meheissen MAM, Garden AS, Mendoza TR, Sturgis EM, Hutcheson KA, Lu C, Aristophanous M, Frank SJ, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Prospective validation and instrumental comparison of the MD Anderson Symptom Inventory—Head and Neck Module for assessment of radiation therapy–attributable late xerostomia. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E538, 2017.
Kamal M, Meheissen MAM, Mohamed ASR, Ding Y, Rostom Y, Hegazy N, Wang J, Elhalawani H, Phan J, Rosenthal DI, Lai SY, Hutcheson KA, Frank SJ, Garden AS, Gunn GB, Fuller CD. Prospective MRI assessment of longitudinal signal kinetics of salivary glands in head and neck cancer patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E345, 2017.
Lewis C, Nurgalieva Z, Gunn GB, Zhao H, Giordano S, Bhayani M, Hutcheson KA. Trends in head and neck cancer post-treatment rehabilitation. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E539, 2017.
Meheissen MAM, Kamal M, Mohamed ASR, Ding Y, Rostom Y, Hegazy N, Elhalawani H, Barrow MP, Eraj S, Rock CD, Wang J, Phan J, Gunn GB, Garden AS, Rosenthal DI, Frank SJ, Hutcheson KA, Fuller CD. Prospective MRI assessment of serial dose-response kinetics of swallowing muscles in oropharyngeal cancer patients treated with radiation therapy and correlations with Dynamic Imaging Grade for Swallowing Toxicity (DIGEST). Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E357-E358, 2017.
Rock CD, Jomaa M, Eraj S, Mohamed ASR, Meheissen MAM, Elhalawani H, Morrison WH, Phan J, Lai S, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-term patient reported symptoms and quality of life in patients >65 following radiation therapy for early stage glottic carcinoma. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E367-E368, 2017.
Rock CD, Jomaa M, Eraj S, Mohamed ASR, Meheissen MAM, Elhalawani H, Morrison WH, Phan, J, Lai S, Sturgis EM, Hutcheson KA, Ferrarotto R, Frank SJ, Rosenthal DI, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following treatment for locally advanced oropharyngeal carcinoma: results from a symptom assessment study. Int J Radiat Oncol Biol Phys 99(2 (Suppl. 1)):E368, 2017.
Mulcahy CF, Mohamed A, Rosenthal DI, Hutcheson KA, Weber RS, Lai SY, Gunn GB, Garden AS, Zafereo M, Morrison WH, Lewin JS, Kies MS, El-Naggar AK, Fuller CD. Comorbidity and survival in locally advanced laryngeal cancer. J Clin Oncol 34(15 (May 20 supplement)):6038, 2016.
Sandulache VC, Hobbs B, Mohamed ASR, Frank SJ, Hazle J, Awan MJ, Rosenthal DI, Garden AS, Gunn GB, Ding Y, Wang J, Colen R, Hutcheson KA, Lewin JS, Chambers MS, Hofstede TM, Weber RS, Lai S, Fuller CD. Dynamic contrast-enhanced MRI detects acute radiation therapy-induced alterations in mandibular microvasculature: prospective assessment of imaging biomarkers of normal tissue injury. Int J Radiat Oncol Biol Phys 94(4):924, 2016.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai S, Schwartz DL, Hutcheson KA. Prospective MD Anderson Dysphagia Inventory outcomes after nonsurgical treatment of locoregionally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 94(4):962-963, 2016.
Hutcheson KA, Sturgis EM, Xu L, Gunn GB, Fuller CD, Mohamed ASR, Lai S, Lewin JS, Chen D. Feeding tube use in patients with salivary gland malignancy. Int J Radiat Oncol Biol Phys 94(4):966, 2016.
Lewin JS, Baumgart LM, Barrow MP, Barringer DA, Hutcheson KA. Device life of the tracheoesophageal voice prosthesis revisited. Int J Radiat Oncol Biol Phys 94(4):967, 2016.
Hutcheson KA, Lin H, Yuk MM, Hubbard RM, Barrow MP, Gunn GB, Fuller CD, Garden AS, Lai S, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Lower cranial neuropathy after oropharyngeal intensity modulated radiation therapy (IMRT): a prospective study and literature review. Int J Radiat Oncol Biol Phys 94(4):968, 2016.
Tucker JR, Xu L, Sturgis EM, Hofstede TM, Chambers MS, Gunn GB, Fuller CD, Mohamed ASR, Lai S, Hutcheson KA. Osteoradionecrosis after radiation therapy for salivary gland malignancies. Int J Radiat Oncol Biol Phys 94(4):970, 2016.
Messer JA, Mohamed ASR, Hutcheson KA, Ding Y, Wang J, Eichelberger H, French C, Rosenthal DI, Gunn GB, Fuller CD. Longitudinal characterization of MRI kinetics in irradiated dysphagia-related structures for nasopharyngeal carcinoma patients receiving IMRT. Int J Radiat Oncol Biol Phys 94(4):224, 2016.
Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou V, Lai S, Gross N, Schwartz DL, Hutcheson KA. Long-term patient-reported dysphagia in low-risk oropharyngeal carcinoma after intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 94(4):340, 2016.
Lee S, Spinks TE, Guzman AB, Weber RS, Hanna EY, Hessel AC, Beadle BM, Hutcheson KA, Incalcaterra J, Wood NM, Jones D, Feeley TW. Measuring value in bundled payments for head and neck cancer. J Clin Oncol 34(7_suppl):11, 2016.
Hutcheson KA, Gunn GB, Gross N, Barrow MP, Kies MS, Garden AS, Schwartz DL, Lewin JS. Prospective longitudinal swallowing outcomes after chemotherapy and split-field IMRT for advanced-stage T1-2 oropharyngeal cancer. Int J Radiat Oncol Biol Phys 93(3):E316, 2015.
Rosenthal DI, Mohamed ASR, Garden AS, Gunn GB, Zafereo M, Phan J, Lai S, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak E, Ginsberg L, Kies MS, Weber RS, Fuller CD. Long-term outcomes following multidisciplinary management of T3 larynx cancer. Int J Radiat Oncol Biol Phys 93(3):E340, 2015.
Messer JA, Mohamed ASR, Ding Y, Wang J, Eichelberger H, French C, Rosenthal DI, Gunn GB, Hutcheson KA, Fuller CD. Characterization of MRI kinectics in irradiated swallowing-related structures for nasopharyngeal carcinoma patients received IMRT. Int J Radiat Oncol Biol Phys 93(3):E343, 2015.
Dale TM, Hutcheson KA, Mohamed ASR, Gunn GB, Rosenthal DI, Fuller CD. Exploratory assessment of swallowing muscle dose volume parameters with chronic dysphagia in patients receiving head and neck chemoradiation therapy. Int J Radiat Oncol Biol Phys 93(3):S171-S172, 2015.
Hutcheson KA, Barringer DA, Gunn B, Lai SY, Barrow M, Lewin JS. Late radiation-associated dysphagia (late-rad) after IMRT for oropharyngeal cancer. Dysphagia 30(5):597, 2015.
Hutcheson KA. Late radiation-associated dysphagia (Late RAD) with lower cranial neuropathy after oropharyngeal IMRT. Oncology 29(4), 2015.
Yuk M, Lewin JS, Gunn BG, Holsinger FC, Hutcheson KA. Late-radiation-associated dysphagia (late-rad) with lower cranial neuropathies (lcnp) in long-term oropharyngeal cancer (opc) survivors: case reports. Dysphagia 29(6):765, 2014.
Holliday E, Garden AS, Fuller CD, Phan J, Gunn GB, Rosenthal DI, Beadle BM, Morrison WH, Zolcak-Uzel E, Zhang X, Zhu XR, Lewis G, Glisson BS, Hutcheson KA, Weber RS, El-Naggar AK, Hong J, Hung T, Frank SJ. Gastrostomy tube rates decrease by over 50% in patients with nasopharyngeal cancer treated with intensity modulated proton therapy (IMPT): a case-controlled study. Int J Radiat Oncol Biol Phys 90(1):S528, 2014.
Lai S, Huang AT, Tang C, Hutcheson KA, Bender M, Beadle BM, Gold KA, Lewin JS. Identification and management of laryngeal carcinoma patients with risk factors for gastrostomy tube placement. Int J Radiat Oncol Biol Phys 90(1):S540-S541, 2014.
Beadle BM, Liao K, Buchholz TA, Garden AS, Hutcheson KA, Guadagnolo B. Differential feeding tube placement and duration with IMRT for head and neck cancer: a SEER-Medicare analysis. Int J Radiat Oncol Biol Phys 90(1):S550-S551, 2014.
Hutcheson KA, Bhayani M, Beadle B, Gold K, Shinn E, Lewin JS. Use it or lose it: swallowing during radiotherapy or chemoradiotherapy for pharyngeal cancers. Dysphagia 28(4):626, 2013.
Shinn E, Garden A, Basen-Engquist K, Sheil C, Alvarez A, Hutcheson KA, Contreras N, Coyne J, Lewin JS. Initial results from Prepare: a randomized adherence intervention trial in head and neck cancer patients. Dysphagia 28(4):642, 2013.
Frank SJ, Rosenthal DI, Ang K., Sturgis EM, Chambers MS, Gunn GB, Hutcheson KA, Zhu XR, Palmer MB, Garden AS. Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients: a case–control study. Int J Radiat Oncol Biol Phys 87(2):S144, 2013.
Hutcheson, K, Awan MJ, Mohamed ASR, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Lewin JS, Fuller CD. Late radiation-associated dysphagia (RAD) and lower cranial neuropathy after oropharyngeal radiation therapy: a case–control dosimetric comparison. Int J Radiat Oncol Biol Phys 87(2):S143, 2013.
Hutcheson KA, Lewin JS, Garden AS, Rosenthal DI, Weber RS, William WN, Gunn GB, Morrison WH, Fuller CD, Frank SJ. Early experience with IMPT for the treatment of oropharyngeal tumors: acute toxicities and swallowing-related outcomes. Int J Radiat Oncol Biol Phys 87(2):S604, 2013.
Setton J, Lee NY, Huang S, Waldron J, O’Sullivan B, Zhang Z, Shi W, Rosenthal DI, Hutcheson KA, Garden AS. A multi-institution pooled analysis of g-tube dependence in patients with oropharyngeal cancer treated with definitive IMRT. Int J Radiat Oncol Biol Phys 88(2):S141, 2013.
Hutcheson KA, Lewin JS, Barringer DA, Lisec A, Gunn BG, Holsinger FC. Failed organ preservation: chronic dysphagia five years or more sfter radiotherapy based treatment of head and neck cancer. Dysphagia 27(4):570, 2012.
Hutcheson K, Alvarez C, Barringer D, LaPine P, Kupferman M, Lewin J. Salvage total laryngectomy for laryngopharyngeal dysfunction after head and neck cancer treatment. Dysphagia 26(4):432, 2011.
Bhayani MK, Hutcheson KA, Barringer DA, Lisec A, Roberts D, Lai SY, Lewin JS. Identification and management of oropharyngeal carcinoma patients with risk factors for gastrostomy tube placement and dependence. Int J Radiat Oncol Biol Phys 81(2):S495, 2011.
Barringer DA, Hutcheson KA, Tucker SL, Dong L, Schwartz DL, Lewin JS. Dosimetric predictors of long-term dysphagia following oropharyngeal IMRT. Dysphagia 24(4):450, 2010.
Lewin JS, Hutcheson KA, Barringer D, Tucker SL, Rosenthal DI, Chao C, Morrison W, Garden AS, Dong L, Schwartz DL. Dosimetric predictors of long-term dysphagia following oropharyngeal IMRT. Int J Radiat Oncol Biol Phys 72((1 Suppl)):S34, 2008.
Hutcheson KA, Barringer DA, Rosenthal DI, May AH, Roberts DB, Lewin JS. Swallowing outcomes after radiotherapy for laryngeal cancer. JAMA 299(16):1881, 2008.
Hutcheson KA, Barringer DA, Davie GL, May AH, Kies MI, Lewin JS. Swallowing outcomes after induction chemotherapy with targeted molecular therapy and radiotherapy for advanced stage head and neck cancer. Dysphagia 23(4):433-434, 2008.
Barringer DA, Hutcheson KA, Sturgis EM, Lewin JS. Does induction chemotherapy change swallowing function in patients with oral tongue cancer?. Dysphagia 23(4):445, 2008.
Lewin JS, Barringer DA, Hutcheson KA, May AM, Rosenthal DI, Robert DB. Swallowing outcomes following radiotherapy for laryngeal carcinoma. Dysphagia 22:382, 2007.
Lewin JS, Holsinger FC, Barringer DA, May AK, Hutcheson KA, Laccourreye O, Diaz Jr, EM. Swallowing outcomes following supracricoid patient laryngectomy in the setting of adjuvant therapy. Arch Otolaryngol Head Neck Surg 132(8):881, 2006.

Book Chapters

Richardson C, Hutcheson KA. Swallowing and communication disorders in head and neck cancer. In: Head and Neck Cancer Rehabilitation. Elsevier, 157-181, 2024.
Roe JWG, Hutcheson KA. Swallowing, voice, and speech disorders after chemoradiation. In: Scott-Brown's Otorhinolaryngology, Head and Neck Surgery. 8th. CRC Press: Abingdon, UK, 532, 2018.
Hutcheson KA, Lewin JS. Dysphagia in patients with head and neck cancer. In: Head and Neck Cancers: Evidenced-Based Treatment. Demos Medical Publishing: New York, NY, 457-477, 2018.
Lewin JS, Hutcheson KA. Speech and Swallowing Impairment. In: Body Image Care for Cancer Patients. 2018. Oxford University Press: New York, 2018.
Neskey DM, Hutcheson KA, Kupferman ME. Cancer of the oropharynx. In: Cancer of the Head and Neck. 5th. Wolters Kluwer: Philadelphia, 347-368, 2017.
Ferrell JK, Grossberg A. Mohamed ASR, Fuller CD, Gold K, Hutcheson KA, Gross ND. Early HPV-related tonsil cancer. In: Oral, Head, and Neck Oncology and Reconstructive Surgery. 1st. Elsevier: Amsterdam, 628-648, 2017.
Hutcheson KA, Lewin JS. Voice rehabilitation after laryngectomy. In: Sataloff's Comprehensive Textbook of Otolaryngology. Jaypee Medical Publishers: Philadelphia, 759-770, 2016.
Hutcheson KA. Rehabilitation of heavily treated head and neck cancer patients. In: Head and Neck Cancer: Multimodality Management. 2nd. Springer: New York, 783-798, 2016.
Hutcheson KA, Pytynia KB, Gunn GB. Cases in oropharyngeal cancer: a multidisciplinary approach. In: Overview of Multidisciplinary Management for Oropharyngeal Cancer. Plural Publishing Inc: San Diego, CA, 49-68, 2016.
Hutcheson KA. Speech therapy multidisciplinary commentary. Optimizing functional outcomes after oral cavity reconstruction: a rehabilitative perspective. In: Reconstructive Plastic Surgery of the Head and Neck: Current Techniques and Flap Atlas. Thieme Medical Publishers, Inc: New York, NY, 37-39, 2016.
Hutcheson KA, Lewis CM. Head and neck cancer survivorship management. In: Advances in Cancer Survivorship Management (MD Anderson Cancer Care Series). Springer: Houston TX, 145-166, 2015.
Lewis CM, Hutcheson KA, Kupferman ME. Comparative effectiveness in head and neck malignancies. In: Comparative Effectiveness in Surgical Oncology. Springer, 89-99, 2015.
Lewin JS, Hutcheson KA. Evaluation and rehabilitation of speech, voice, and swallowing function after treatment of head and neck cancer. In: Head and Neck Cancer: A Multidisciplinary Approach. 4th. Lippincott, Williams & Wilkins: Philadelphia, PA, 225-235, 2013.
Lewin JS, Hutcheson KA, Barringer DA. Supracricoid laryngectomy (SCPL). In: Dysphagia in Rare Conditions. Plural Publishing Inc: San Diego, CA, 2009.
Lewin JS, Hutcheson KA. General principles of rehabilitation of speech, voice, and swallowing after treatment of head and neck cancer. In: Head and Neck Cancer: A Multidisciplinary Approach. 3rd. Lippincott Williams & Wilkins: New York, NY, 168-177, 2008.
Hutcheson KA. Speech and swallowing rehabilitation. In: Stell & Maran's Textbook of Head and Neck Surgery and Oncology. 6.
Hutcheson, et al. Communication and Swallowing Dysfunction in the Cancer Patient. In: Cancer Rehabilitation: Principles and Practice, 3e. Springer Publishing.
Burns C, Cunningham C, Hutcheson KA. Supporting head and neck cancer management: Use of technology. In: Head and Neck Cancer: Treatment Rehabilitation & Outcomes.

Letters to the Editor

Starmer H, Hutcheson KA. Intra and interobserver agreement of the Dynamic Imaging Grade of Swallowing Toxicity Scale (DIGEST) in fiberoptic endoscopic evaluation of swallowing (FEES): the importance of observer-tailored training. European Archives of Oto-Rhino-Laryngology 280: 3045–3046, 2023.
McDowell L, Hutcheson KA, Ringash J. DO-IMRT, the MDADI, and swallowing-related quality of life. The Lancet, 2023.

Read More

Less

Grant & Contract Support

Date: 2024 - 2029
Title: inHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery - MPI - PI Project 3
Funding Source: NIH/NCI
Role: Collaborator
ID: 1P01CA278716-01A1
Date: 2020 - 2021
Title: Determining the clinical utility of the caregiver analysis of reported disorders (CARES) questionnaire
Funding Source: McMaster University
Role: M-DATT Co-Investigator
ID: FP00010832
Date: 2016 - 2018
Title: A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Co-Investigator
ID: RP150386
Date: 2016 - 2017
Title: Characterization of Laryngectomy Stoma Structure-Function
Funding Source: Gromada
Role: Co-Investigator
ID: Pending
Date: 2016 - 2021
Title: Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source: NIH/NIDCR
Role: Co-Investigator
ID: 1R01DE025248-03
Date: 2015 - 2017
Title: Toward Preventing Pneumonia in Chronic Aspirators after Head and Neck Radiotherapy
Funding Source: The University of Texas MD Anderson Cancer Center Institutional Survivorship Seed Money Research Grant
Role: Principal Investigator
ID: 2015-00051041
Date: 2015 - 2016
Title: Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Osteoradionecrosis
Funding Source: NIH/NIDCR
Role: Co-Investigator
ID: 1R56DE025248-01
Date: 2015 - 2017
Title: Optimizing Post-Treatment Surveillance of Head and Neck Cancer
Funding Source: The University of Texas MD Anderson Cancer Center Institutional Survivorship Seed Money Research Grant
Role: Co-Investigator
ID: 2016-0051896
Date: 2015 - 2018
Title: Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation
Funding Source: NIH/NCI
Role: Principal Investigator
ID: 1R03CA188162-01A1
Date: 2014 - 2023
Title: Patient-Reported Outcomes/Function (PROF) Section
Funding Source: Steifel Oropharyngeal Research Fund
Role: Principal Investigator
ID: 2016-00051834
Date: 2014 - 2018
Title: Videofluoroscopic Grading of Dysphagia in Organ Preservation Trials
Funding Source: MD Anderson Cancer Center - Institutional Research Grant
Role: Principal Investigator
ID: 2016-00052317
Date: 2014 - 2018
Title: Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
Funding Source: Velindre NHS Trust (Prime: Cancer Research United Kingdom)
Role: Co-Investigator
ID: C36244/A17161
Date: 2013 - 2017
Title: Determining the Extent of Dysphagia using the Modified Barium Swallow for RTOG 1221, a Randomized Phase II Trial of Transoral Endoscopic Head and Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer
Funding Source: Radiation Therapy Oncology Group (BIQSFP)
Role: Co-Investigator
ID: RTOG 1221
Date: 2012 - Present
Title: NIR Fluorescence Imaging for Assessment of Lymphatics in Cancer Treatment and Recovery
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Consultant
ID: RP120941
Date: 2011 - 2013
Title: A Retrospective Review of the MD Anderson Experience with the Provox NiD Prosthesis
Funding Source: ATOS Medical, Inc
Role: Co-Investigator
ID: CS2012-00035931LG 01
Date: 2011 - 2013
Title: UT Health Innovation for Cancer Prevention Research Fellowship, The University of Texas School of Public Health
Funding Source: Cancer Prevention & Research Institute of Texas (CPRIT)
Role: Research Fellow

Patient Reviews

CV information above last modified January 23, 2025

Request an Appointment

Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.

Learn more

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.

Learn more

Help #EndCancer

Give Now

Your gift will help make a tremendous difference.

Donate

Donate Blood

Giving blood and platelets provides hope for cancer patients who depend on the generosity of donors like you.

Learn more

Volunteer

Change the lives of cancer patients by giving your time and talent.

Subscribe to our Cancerwise newsletter

Explore

Patients & Family

Prevention & Screening

Donors & Volunteers

For Physicians

Research

Education & Training

Clinical Trials

Languages

About

About MD Anderson

Careers

Blog

Newsroom

For Employees

Title IX Reporting (Sexual Misconduct)

Price Transparency

Finding Your Way

Our Doctors

Locations

Directions

Sitemap

DIGITAL ACCESSIBILITY

Accessibility Policy

GET IN TOUCH

Call
1-877-632-6789

Ask a question

Stay Connected

More

Privacy Policy

Legal Statement & Policies

Reports to the State

Emergency Alert Information

State of Texas Links

MD Anderson Cancer Network

Vendors & Suppliers

© 2025 The University of Texas MD Anderson Cancer Center

Katherine A. Hutcheson, Ph.D.

About Dr. Katherine A. Hutcheson

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Research Interests

Education & Training

Degree-Granting Education

Board Certifications

Experience & Service

Academic Appointments

Administrative Appointments/Responsibilities

Other Appointments/Responsibilities

Institutional Committee Activities

Honors & Awards

Professional Memberships

Selected Publications

Peer-Reviewed Articles

Invited Articles

Other Articles

Abstracts

Book Chapters

Letters to the Editor

Grant & Contract Support

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Date:	2024 - 2029
Title:	inHANCE: Imaging Innovation for Head And Neck Cancer Evaluation & Treatment Delivery - MPI - PI Project 3
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	1P01CA278716-01A1

Date:	2020 - 2021
Title:	Determining the clinical utility of the caregiver analysis of reported disorders (CARES) questionnaire
Funding Source:	McMaster University
Role:	M-DATT Co-Investigator
ID:	FP00010832

Date:	2016 - 2018
Title:	A Phase I Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Advanced Laryngeal Cancer
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Co-Investigator
ID:	RP150386

Date:	2016 - 2017
Title:	Characterization of Laryngectomy Stoma Structure-Function
Funding Source:	Gromada
Role:	Co-Investigator
ID:	Pending

Date:	2016 - 2021
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Clinical Outcome Measures for Mandibular Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-Investigator
ID:	1R01DE025248-03

Date:	2015 - 2017
Title:	Toward Preventing Pneumonia in Chronic Aspirators after Head and Neck Radiotherapy
Funding Source:	The University of Texas MD Anderson Cancer Center Institutional Survivorship Seed Money Research Grant
Role:	Principal Investigator
ID:	2015-00051041

Date:	2015 - 2016
Title:	Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Establish Objective Osteoradionecrosis
Funding Source:	NIH/NIDCR
Role:	Co-Investigator
ID:	1R56DE025248-01

Date:	2015 - 2018
Title:	Lingual Strength & Dysphagia after Oropharynx Cancer: Proton vs. Photon Radiation
Funding Source:	NIH/NCI
Role:	Principal Investigator
ID:	1R03CA188162-01A1

Date:	2014 - 2023
Title:	Patient-Reported Outcomes/Function (PROF) Section
Funding Source:	Steifel Oropharyngeal Research Fund
Role:	Principal Investigator
ID:	2016-00051834

Date:	2014 - 2018
Title:	Videofluoroscopic Grading of Dysphagia in Organ Preservation Trials
Funding Source:	MD Anderson Cancer Center - Institutional Research Grant
Role:	Principal Investigator
ID:	2016-00052317

Date:	2013 - 2017
Title:	Determining the Extent of Dysphagia using the Modified Barium Swallow for RTOG 1221, a Randomized Phase II Trial of Transoral Endoscopic Head and Neck Surgery followed by Risk-Based IMRT and Weekly Cisplatin versus IMRT and Weekly Cisplatin for HPV Negative Oropharynx Cancer
Funding Source:	Radiation Therapy Oncology Group (BIQSFP)
Role:	Co-Investigator
ID:	RTOG 1221

Date:	2012 - Present
Title:	NIR Fluorescence Imaging for Assessment of Lymphatics in Cancer Treatment and Recovery
Funding Source:	Cancer Prevention & Research Institute of Texas (CPRIT)
Role:	Consultant
ID:	RP120941

Date:	2011 - 2013
Title:	A Retrospective Review of the MD Anderson Experience with the Provox NiD Prosthesis
Funding Source:	ATOS Medical, Inc
Role:	Co-Investigator
ID:	CS2012-00035931LG 01